Skip to content
Medical Health Aged Care, Science

Drinking less could prevent thousands of cancer deaths, study shows

La Trobe University 2 mins read

Reducing annual alcohol consumption in Australia by one litre a person could significantly lower deaths from several major cancers, particularly among older Australians, a new study led by La Trobe University has found.

Using more than 70 years of national mortality, alcohol and tobacco consumption, and health-expenditure data, researchers examined how long-term population level alcohol consumption in Australia is associated with mortality from four alcohol-related cancers.

Published in the British Journal of Cancer, the study said that long-term alcohol exposure was a causal factor in:

  • Some 45 per cent of male upper aerodigestive tract (UADT) cancer deaths
  • About 21 per cent of female UADT cancer deaths
  • About 48 per cent of male liver cancer deaths
  • About 15 per cent of male colorectal cancer deaths and 4% for females
  • 14 per cent of female breast cancer deaths

 

The researchers said these estimates are higher than in previous Australian studies, reflecting the cumulative effects of decades of drinking.

The strongest alcohol-related cancer impacts were seen in people aged 50 years and older. The researchers warn that with Australia’s ageing population — and older cohorts drinking more than younger ones — alcohol-related cancer deaths could rise without preventive action such as closing tax loopholes and using warning labels.

However, the researchers found that reducing alcohol consumption by one litre per person each year could lead to a reduction in alcohol-related cancer deaths of:

  • 3.6 per cent fewer UADT cancer deaths in men and 3.4% fewer in women
  • 3.9 per cent fewer male liver cancer deaths
  • 1.2 per cent fewer male colorectal cancer deaths and 0.7% fewer in women
  • 2.3 per cent fewer female breast cancer deaths

 

Lead author Associate Professor Jason Jiang, from La Trobe’s Department of Public Health and Centre for Alcohol Policy Research (CAPR), said this was the first study to examine the associations between alcohol consumption and mortality from these cancers in Australia using long-term aggregate data.

“The study provides robust evidence that reducing population-level alcohol consumption in Australia could substantially lower mortality from UADT, colorectal, male liver and female breast cancers, particularly among older adults,” Associate Professor Jiang said.

The study said that reducing population-wide drinking through proven policies such as alcohol taxation, regulating availability and limiting advertising could deliver substantial reductions in cancer mortality.

It pointed to the Australian Guidelines to Reduce Health Risk from Drinking Alcohol, which state males and females should drink no more than 10 standard drinks a week and no more than four standard drinks on any one day to reduce the lifetime risk of harm attributed to alcohol, such as cancer, cardiovascular diseases and mental disorders.

“Although the WHO states that there is no level of alcohol consumption that is safe for risk of cancer, if more of the population followed drinking guidelines it would considerably reduce the risk of developing alcohol-related cancers substantially,” Associate Professor Jiang said.

The research was conducted by La Trobe University, the University of Melbourne, Curtin University and partner institutions, using publicly available national datasets and advanced time-series modelling techniques.

Read the full study here: Alcohol consumption and mortality from four alcohol-related cancers in Australia 1950-2018: a time series analysis

Associate Professor Jason Jiang is available for interviews.

MEDIA ENQUIRIES

[email protected]

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 08:00
Monash University

New clinical trial to compare the effectiveness of IV treatments for severe asthma in children

A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ahead thanks to an almost $5 million Medical Research Future Fund grant. The clinical trial – spearheaded by Professor Simon Craig, Adjunct Clinical Professor in the School of Clinical Sciences at Monash Health and paediatric emergency medicine physician at Monash Medical Centre – will provide clinicians with clear evidence to make more informed decisions, provide faster and more effective treatment, reduce unnecessary variation between hospitals, and ultimately improve outcomes for children with severe asthma. “Asthma is one of the most common reasons children…

  • Medical Health Aged Care
  • 22/01/2026
  • 03:41
Galderma

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

ZUG, Switzerland–BUSINESS WIRE– Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming…

  • Contains:
  • Medical Health Aged Care
  • 21/01/2026
  • 20:10
Ramsay Health Care

St George Private Hospital begins $16.4m expansion to strengthen patient care

Key Facts: $16.4m expansion project at St George Private Hospital (Sydney) will add 2 fully equipped operating theatres plus 2 future theatre spaces Project…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.